Cognitive deficits, which play a crucial role in the pathogenesis and prognosis of schizophrenia, can lead to noncompliance and poor outcomes. New treatment options need to be tested that may offer surplus effects on neurocognition.
Steffen Moritz, PhD
Advertisement
Articles by Steffen Moritz, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Issues CRL for CTx-1301 for Treatment of ADHD
2
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
3
New Name, New Path for Psychiatry: The Future of the DSM
4
Endangered Education: Psychiatric Professional Degrees Under Attack
5